Showing results (171-180 of 228) with videos related to
Sort By:
Pageof 23
The Lancet. Oncology|August 31, 2020
Veliparib with carboplatin and paclitaxel in BRCA-mutated advanced breast cancer (BROCADE3): a randomised, double-blind, placebo-controlled, phase 3 trialVéronique Diéras, Hyo S Han, Bella Kaufman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 29, 2019
Neoadjuvant Talazoparib for Patients With Operable Breast Cancer With a Germline BRCA Pathogenic VariantJennifer K Litton, Marion E Scoggins, Kenneth R Hess, et al.BMC Cancer|August 15, 2024
Monitoring response to neoadjuvant chemotherapy in triple negative breast cancer using circulating tumor DNAJennifer H Chen, Sridevi Addanki, Dhruvajyoti Roy, et al.International Journal of Radiation Oncology, Biology, Physics|September 28, 2021
Breast Radiation Therapy-Related Treatment Outcomes in Patients With or Without Germline Mutations on Multigene Panel TestingBhavana V Chapman, Diane Liu, Yu Shen, et al.International Journal of Radiation Oncology, Biology, Physics|October 5, 2021
Outcomes After Breast Radiation Therapy in a Diverse Patient Cohort With a Germline BRCA1/2 MutationBhavana V Chapman, Diane Liu, Yu Shen, et al.Breast Cancer Research and Treatment|June 1, 2026
Non-BRCA germline pathogenic variants and response to neoadjuvant systemic therapy in triple-negative breast cancer patients enrolled in a prospective clinical trialKamaria L Lee, Clinton Yam, Li Zhao, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 2, 2005
Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancerAman U Buzdar, Nuhad K Ibrahim, Deborah Francis, et al.Journal of Genetic Counseling|May 18, 2018
Creation and Implementation of an Environmental Scan to Assess Cancer Genetics Services at Three Oncology Care SettingsErica M Bednar, Michael T Walsh, Ellen Baker, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 22, 2018
Multicenter Phase II Study of Lurbinectedin in BRCA-Mutated and Unselected Metastatic Advanced Breast Cancer and Biomarker Assessment SubstudyCristina Cruz, Alba Llop-Guevara, Judy E Garber, et al.JAMA Oncology|June 8, 2018
Safety and Efficacy of Panitumumab Plus Neoadjuvant Chemotherapy in Patients With Primary HER2-Negative Inflammatory Breast CancerNaoko Matsuda, Xiaoping Wang, Bora Lim, et al.Pageof 23